Cargando…
Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
BACKGROUND: Activation of epidermal growth factor receptor (EGFR) has been reported in a variety of cancer types, including colorectal cancer (CRC), and represents a potential chemotherapeutic drug target. EGFR tyrosine kinase inhibitors (EGFR-TKIs) have been increasingly applied in the clinical tre...
Autores principales: | Zhuang, Yan, Bai, Ying, Hu, Yan, Guo, Yueqin, Xu, Lingyuan, Hu, Wanle, Yang, Lehe, Zhao, Chengguang, Li, Xiaokun, Zhao, Haiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618855/ https://www.ncbi.nlm.nih.gov/pubmed/31308698 http://dx.doi.org/10.2147/OTT.S206833 |
Ejemplares similares
-
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019) -
Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019) -
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2020) -
Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021) -
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
por: Bai, Encheng, et al.
Publicado: (2018)